Multicentre prospective validation of a urinary peptidome-based classifier for the diagnosis of type 2 diabetic nephropathy

Global Prevalence of Diabetes

2004 • 15,420 citations

Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy

2001 • 7,165 citations

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38

1998 • 6,576 citations

Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate

2006 • 5,420 citations

The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic Nephropathy

1993 • 5,296 citations

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38

1998 • 4,813 citations

Chronic kidney disease: global dimension and perspectives

2013 • 3,829 citations

National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants

2011 • 3,511 citations

Chronic kidney disease: the global challenge

2005 • 1,118 citations

Naturally Occurring Human Urinary Peptides for Use in Diagnosis of Chronic Kidney Disease

2010 • 485 citations

Recommendations for Biomarker Identification and Qualification in Clinical Proteomics

2010 • 306 citations

In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria

2009 • 276 citations

Mechanisms and Treatment of CKD

2012 • 258 citations

Urinary Proteomics for Early Diagnosis in Diabetic Nephropathy

2012 • 250 citations

Quantitative Urinary Proteome Analysis for Biomarker Evaluation in Chronic Kidney Disease

2008 • 248 citations

Receiver operating characteristic laboratory (ROCLAB): Software for developing decision strategies that account for uncertainty

2002 • 215 citations

Urine Biomarkers Predict the Cause of Glomerular Disease

2007 • 215 citations

CE‐MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics

2008 • 205 citations

Mass spectrometry for the detection of differentially expressed proteins: a comparison of surface‐enhanced laser desorption/ionization and capillary electrophoresis/mass spectrometry

2003 • 203 citations

Technical aspects and inter-laboratory variability in native peptide profiling: The CE–MS experience

2012 • 194 citations

Chronic kidney disease: the global challenge

2005 • 172 citations

Implementation of proteomic biomarkers: making it work

2012 • 155 citations

Discovery and validation of urinary biomarkers for prostate cancer

2008 • 144 citations

Repetitive Fragmentation Products of Albumin and α1-Antitrypsin in Glomerular Diseases Associated with Nephrotic Syndrome

2006 • 136 citations

A urinary peptide biomarker set predicts worsening of albuminuria in type 2 diabetes mellitus

2012 • 136 citations

CKD273, a New Proteomics Classifier Assessing CKD and Its Prognosis

2013 • 135 citations

Discovery of biomarkers in human urine and cerebrospinal fluid by capillary electrophoresis coupled to mass spectrometry: Towards new diagnostic and therapeutic approaches

2005 • 128 citations

Addressing the Challenge of Defining Valid Proteomic Biomarkers and Classifiers

2010 • 114 citations

Human urinary peptide database for multiple disease biomarker discovery

2011 • 112 citations

Identification and Validation of Urinary Biomarkers for Differential Diagnosis and Evaluation of Therapeutic Intervention in Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis

2009 • 111 citations

The urinary proteome in diabetes and diabetes‐associated complications: New ways to assess disease progression and evaluate therapy

2008 • 73 citations

A comparison between MALDI-MS and CE-MS data for biomarker assessment in chronic kidney diseases

2012 • 64 citations

Debate: CON Position. Should Microalbuminuria Ever Be Considered as a Renal Endpoint in Any Clinical Trial

2010 • 51 citations

Chronic kidney disease: a new look at pathogenetic mechanisms and treatment options

2013 • 45 citations

Debate: PRO Position. Should Microalbuminuria Ever Be Considered as a Renal Endpoint in Any Clinical Trial

2010 • 41 citations

How to get proteomics to the clinic? Issues in clinical proteomics, exemplified by <scp>CE</scp>‐<scp>MS</scp>

2012 • 23 citations

Proteomic analysis of alpha‐1‐antitrypsin in immunoglobulin A nephropathy

2007 • 14 citations

Two-Dimensional Gel Electrophoresis of Urinary Proteins in Kidney Diseases

2015 • 10 citations